| Study Of Eribulin (E7389) In Patients With Advanced Solid Tumors And Normal Or Reduced Hepatic Function As Per Child-Pugh System (NCT00706095) | Eisai Inc. | 2008-02-01 |
| Do Self-Rated Performance Status Scores Correlate With Health-Care-Provider-Scores? (NCT00735111) | University of Florida | 2008-02-01 |
| A Phase 1 Study of ARQ 197 in Adult Patients With Advanced Solid Tumors (NCT00612703) | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | 2008-02-01 |
| PORTAS 2, Comparing Venae Sectio Versus Punction of Vena Subclavia for Insertion of a Totally Implantable Access Port (NCT00600444) | Heidelberg University | 2008-02-01 |
| Pharmacokinetics Study of Liposomal Paclitaxel in Humans (NCT00606515) | Shandong Luye Pharmaceutical Co., Ltd. | 2008-02-01 |
| Phase 1/2 Study of Vascular Disrupting Agent NPI-2358 + Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer (NCT00630110) | Nereus Pharmaceuticals, Inc. | 2008-02-01 |
| Drug Use Investigation for ARRANON G (Nelarabine) Injection 250mg (NCT01376115) | Novartis Pharmaceuticals | 2008-01-18 |
| Detection of Chemotherapy Induced Cardiotoxicity (NCT00636844) | George Washington University | 2008-01-01 |
| Women With Cancer: An Exercise Study to Promote Health (NCT01102985) | Yale University | 2008-01-01 |
| An Efficacy and Safety Study of Fentanyl (JNS020QD) in Participants With Cancer Pain (NCT00641667) | Janssen Pharmaceutical K.K. | 2008-01-01 |
| A Phase I, Dose-Escalation Study to Assess the Safety and Drug Levels in Blood of AZD4877 in Japanese Adult Patients (NCT00613652) | AstraZeneca | 2008-01-01 |
| Time From PCI to Cancer Surgery and Cardiovascular and Oncologic Outcomes (NCT06357000) | Samsung Medical Center | 2008-01-01 |
| Pharmacokinetics and Metabolism of Radiolabeled BMS-690514 in Healthy Male Subjects (NCT00578916) | Bristol-Myers Squibb | 2008-01-01 |
| The Effects of a Meditation Retreat on Healthy Volunteers and Cancer Patients: an fMRI Study (NCT00878735) | Hospital Israelita Albert Einstein | 2008-01-01 |
| A Phase 1 Study of ARQ 197 in Patients With Solid Tumors (NCT00609921) | Kyowa Kirin Co., Ltd. | 2008-01-01 |
| Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant (NCT00617929) | Masonic Cancer Center, University of Minnesota | 2008-01-01 |
| Safety And PK Study Of CVX-060 In Patients With Advanced Solid Tumors (NCT00879684) | Pfizer | 2008-01-01 |
| Trial of MSC1936369B in Subjects With Solid Tumors (NCT00982865) | Merck KGaA, Darmstadt, Germany | 2007-12-31 |
| A Dose-Finding Study of Fentanyl (JNS020 QD) 1-Day Transdermal Patch in Participants With Cancer Pain (NCT00644787) | Janssen Pharmaceutical K.K. | 2007-12-01 |
| Statin Therapy Versus Placebo Prior to Prostatectomy (NCT00572468) | VA Office of Research and Development | 2007-12-01 |
| Open Label Phase 1 Dose Finding Study of TRC105 in Patients With Solid Cancer (NCT00582985) | Tracon Pharmaceuticals Inc. | 2007-12-01 |
| Phase I Study of Sorafenib Dosed Continuously With Cyclophosphamide and Doxorubicin (NCT00562913) | Bayer | 2007-12-01 |
| Improving Cancer Pain Management Through Self-Care (NCT00708019) | University of California, San Francisco | 2007-12-01 |
| Long-term Safety and Efficacy Study of Fentanyl Sublingual Spray for the Treatment of Breakthrough Cancer Pain (NCT00538863) | INSYS Therapeutics Inc | 2007-12-01 |
| Effect of Topical Morphine (Mouthwash) on Oral Pain Due to Chemo- and/or Radiotherapy Induced Mucositis (NCT00613743) | University Hospital, Geneva | 2007-12-01 |
| Phase III Study of PI-88 in Post-resection Hepatocellular Carcinoma (NCT00568308) | Progen Pharmaceuticals | 2007-12-01 |
| Edinburgh Pain Assessment Tool (EPAT©) Study (NCT00595777) | University of Edinburgh | 2007-12-01 |
| Combination of Hydroxyurea and Verapamil for Refractory Meningiomas (NCT00706810) | University of Utah | 2007-12-01 |
| Regional Anesthesia and Endometrial Cancer Recurrence (NCT00531349) | The Cleveland Clinic | 2007-11-01 |
| A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (NCT00530764) | GW Pharmaceuticals Ltd | 2007-11-01 |
| Radiation Biodosimetry in Patients Treated With Total Body Irradiation (TBI) (NCT00581958) | Memorial Sloan Kettering Cancer Center | 2007-11-01 |
| A Study to Investigate the Effect of Food on Oral LBH589 Absorption in Patients With Advanced Solid Tumors (NCT00570284) | Novartis Pharmaceuticals | 2007-11-01 |
| Phase I Study of BMS-690514 in Japanese Patients With Solid Tumors (NCT00516451) | Bristol-Myers Squibb | 2007-11-01 |
| Radiotherapy Plus Panitumumab Compared to Chemoradiotherapy With Unresected, Locally Advanced Squamous Cell Carcinoma of the Head and Neck (NCT00547157) | Amgen | 2007-11-01 |
| The Biodistribution of 1-[2 Deoxy-2, -18 Fluroarabinfuranosyl]Cytosine [18FAC] in Healthy Subjects and Patients With Cancer, Autoimmune/Inflammatory Diseases (NCT01180907) | Jonsson Comprehensive Cancer Center | 2007-11-01 |
| [F-18] Fluorothymidine (FLT) Imaging on Patients With Primary Brain Tumors (NCT00707343) | University of Utah | 2007-10-31 |
| PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer) (NCT00446446) | Amgen | 2007-10-30 |
| Efficacy Study of Recombinant Interleukin-21 in the Treatment of Ovarian Cancer (NCT00523380) | Novo Nordisk A/S | 2007-10-04 |
| Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain (NCT00538850) | INSYS Therapeutics Inc | 2007-10-01 |
| A Phase II Open Label, Multi-Center Study With AVR118 in Anorectic Patients With Recurrent or Advanced Malignancies (NCT00765466) | McGill University | 2007-10-01 |
| T-Regulatory Cell Kinetics, Stem Cell Transplantation, REGKINE (NCT00578461) | Baylor College of Medicine | 2007-10-01 |
| Cancer Patients' Knowledge About Fatigue (NCT00927433) | Oslo University Hospital | 2007-10-01 |
| Drug Utilization Prevalence in a Pediatric Care Medical Center (NCT00550706) | Rambam Health Care Campus | 2007-10-01 |
| Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial (NCT00904514) | National Institutes of Health Clinical Center (CC) | 2007-10-01 |
| Establishment of a Lifetime of Cohort of Adults Surviving Childhood Cancer (NCT00760656) | St. Jude Children's Research Hospital | 2007-09-13 |
| Combination Trial of BMS-690514 in Combination With FOLFIRI and FOLFOX (NCT00479583) | Bristol-Myers Squibb | 2007-09-01 |
| Cancer Symptom Monitoring Telephone System With Nurse Practitioner (NP) Follow up (NCT01973946) | University of Utah | 2007-09-01 |
| Study of the Efficacy of Kalinox® 170 Bar in Adult Oncology (NCT00646945) | Air Liquide Santé International | 2007-09-01 |
| Oxycodone and Pregabalin for the Treatment of Oncological Neuropathic Pain (NCT00637975) | Associazione Progetto Oncologia UMAN.A | 2007-09-01 |
| First Study of the Safety of CNTO 888 in Patients With Solid Tumors (NCT00537368) | Centocor, Inc. | 2007-09-01 |
| Feasibility Study of Pazopanib in Combination With Chemotherapy in Gynaecological Tumors (NCT00561795) | GlaxoSmithKline | 2007-09-01 |
| Open-Label Study to Determine the Maximum Tolerated Oral Dose of the Kinase Inhibitor CEP-11981 in Patients With Advanced Cancer (NCT00875264) | Cephalon | 2007-09-01 |
| Non-invasive Ventilation in Terminally Ill Cancer Patients (NCT00533143) | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2007-09-01 |
| Study of XL228 Administered Intravenously to Subjects With Advanced Malignancies (NCT00526838) | Exelixis | 2007-09-01 |
| External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases (NCT00637637) | Oncology Institute of Southern Switzerland | 2007-09-01 |
| A Study Comparing Oxycodone to Oxycodone/Naloxone in Moderate to Severe, Chronic Cancer Pain (NCT00513656) | Mundipharma Research GmbH & Co KG | 2007-09-01 |
| Vibration Response Imaging (VRI) in Patients That Are Candidates for Undergoing Pulmonary Operation Procedure (NCT00523094) | Deep Breeze | 2007-09-01 |
| Laser Acupuncture Against Nausea in Children (NCT00528554) | University Children Hospital Homburg | 2007-09-01 |
| A Study of the Interaction of Rifampin and Vinflunine in Subjects With Advanced Cancer (NCT00534807) | Bristol-Myers Squibb | 2007-09-01 |
| FDG-Positron Emission Tomography (PET)/CT In the Evaluation of Persistent Febrile Neutropenia in Cancer Patients (NCT00707213) | University of Utah | 2007-08-21 |
| A Efficacy and Safety Trial of Controlled Release (CR) Morphine in Cancer Patients (NCT00446069) | Egalet Ltd | 2007-08-01 |
| The Effect of Chemotherapy on Lactate Threshold in Cancer Patients (NCT01335555) | Liverpool University Hospitals NHS Foundation Trust | 2007-08-01 |
| Bevacizumab (Avastin®) + Erlotinib as First-line Therapy for Stage IIIB/IV or Recurrent, Non-squamous Cell Lung Cancer (NCT00585377) | University of Utah | 2007-08-01 |
| A Safety and Pharmacokinetic Study of TAK-285 in Patients With Advanced Cancer (NCT00535522) | Millennium Pharmaceuticals, Inc. | 2007-08-01 |
| Thyroid Cancer and Sunitinib (NCT00510640) | University Hospital, Bordeaux | 2007-08-01 |
| Safety Study of PRLX 93936 in Patients With Advanced Solid Tumors (NCT00528047) | Prolexys Pharmaceuticals | 2007-08-01 |
| A Study to Test V930/V932 in Patients With Cancers Expressing Human Epidermal Growth Factor Receptor 2 (HER-2) and/or Carcinoembryonic Antigen (CEA)(V930-003)(COMPLETED) (NCT00647114) | Merck Sharp & Dohme LLC | 2007-08-01 |
| Clinical Evaluation of an Investigational Blood Creatinine Point-of-Care Test Device (NCT00607529) | Memorial Sloan Kettering Cancer Center | 2007-08-01 |
| The Pharmacokinetics and Safety Characteristics of Docetaxel in Patients With Cancer (NCT01268163) | Hospira, now a wholly owned subsidiary of Pfizer | 2007-08-01 |
| Combination of Recombinant Human IL-21 (rIL-21) and Sunitinib in Stage IV Renal Cell Carcinoma Patients (NCT00617253) | Novo Nordisk A/S | 2007-07-12 |
| 3 Screen Electronic Alert (NCT00550082) | Brigham and Women's Hospital | 2007-07-01 |
| Seeking Informed Consent to Phase I Cancer Clinical Trials: Identifying Oncologists'Communication Styles (NCT00582192) | Memorial Sloan Kettering Cancer Center | 2007-07-01 |
| A Phase I Study of the Chimeric Anti-CD40 Monoclonal Antibody ChiLob 7/4 to Treat Advanced Malignancies Refractory to Conventional Anti-cancer Treatment (NCT01561911) | Cancer Research UK | 2007-07-01 |
| A Dose Escalation Study of E7107 Administered Intravenously on Days 1 and 8 Every 21 Days to Patients With Solid Tumors (NCT00499499) | Eisai Inc. | 2007-07-01 |
| Occupational Therapy Modulates the Pain in Cancer Patient Under Palliative Care (NCT02102178) | Barretos Cancer Hospital | 2007-07-01 |
| Phase I Study to Assess the Safety, Pharmacokinetics, & Pharmacodynamics of GSK923295 in Subjects w/ Refractory Cancer (NCT00504790) | GlaxoSmithKline | 2007-06-25 |
| Strength Training and Nutrition Development for African American Youth (NCT01441323) | University of Southern California | 2007-06-01 |
| Safety and Efficacy of PMI-150 (Intranasal Ketamine) for the Treatment of Breakthrough Pain in Cancer Patients (NCT00492388) | Hospira, now a wholly owned subsidiary of Pfizer | 2007-06-01 |
| Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy (NCT00509691) | University of Louisville | 2007-06-01 |
| Phase 1, Open-label, Dose Escalation Study of TRC093, in Patients With Locally Advanced or Metastatic Solid Tumors (NCT00492830) | Tracon Pharmaceuticals Inc. | 2007-06-01 |
| Study of the Safety and Pharmacokinetics of XL765 (SAR245409) in Adults With Solid Tumors (NCT00485719) | Sanofi | 2007-06-01 |
| Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer (NCT00499733) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2007-06-01 |
| Safety And Pharmacology Study Of SNX-5422 Mesylate In Subjects With Refractory Solid Tumor Malignancies (NCT00506805) | Esanex Inc. | 2007-06-01 |
| A Study of Safety, Tolerability, and Pk of rhMBL in Pediatric Hematology/Oncology Pts With Fever and Neutropenia (NCT00520325) | Enzon Pharmaceuticals, Inc. | 2007-06-01 |
| Study of the Safety and Pharmacokinetics of XL147 (SAR245408) in Adults With Solid Tumors or Lymphoma (NCT00486135) | Sanofi | 2007-06-01 |
| A Study to Evaluate the Effectiveness and Safety of CG5503 (Tapentadol) in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine (NCT00505414) | Grünenthal GmbH | 2007-06-01 |
| A Multi-modality Imaging Assessment of Chemobrain (NCT00708045) | University of Utah | 2007-05-09 |
| A Study of XL844 Administered as a Single Agent and in Combination With Gemcitabine in Adults With Advanced Malignancies (NCT00475917) | Exelixis | 2007-05-01 |
| Phase I Single Ascending Dose/Multiple Ascending Dose in Patients Treated With AZD7762 and Irinotecan (NCT00473616) | AstraZeneca | 2007-05-01 |
| Ashwagandha: Effects on Stress, Inflammation and Immune Cell Activation (NCT00817752) | National University of Natural Medicine | 2007-05-01 |
| Bevacizumab Treatment and Retinal Vessel Monitoring (NCT00740168) | Technische Universität Dresden | 2007-05-01 |
| Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant (NCT00569283) | Asan Medical Center | 2007-05-01 |
| A Study of Radiation With Sorafenib in Advanced Cancer (NCT00610246) | University Health Network, Toronto | 2007-05-01 |
| Cancer Dietary Objectives Study (NCT00561977) | University of Massachusetts, Worcester | 2007-05-01 |
| A Dose Escalation Study of E7107 Administered IV (Bolus) on Days 1, 8, and 15 Every 28 Days to Patients With Solid Tumours (NCT00459823) | Eisai Limited | 2007-05-01 |
| Randomized Discontinuation Study of Lapatinib Versus Placebo in Subjects With Documented Tumor Progression After Chemotherapy, or Where no Approved Therapy Exists (NCT00447226) | GlaxoSmithKline | 2007-05-01 |
| Open-label Study to Investigate the Safety, Tolerability, PK, and Pharmacodynamics of the AKT Inhibitor GSK690693 (NCT00493818) | GlaxoSmithKline | 2007-04-01 |
| Psychopharmacology of Psilocybin in Cancer Patients (NCT00465595) | Johns Hopkins University | 2007-04-01 |
| Brief CBT for Anxiety and Advanced Cancer (NCT00706290) | Massachusetts General Hospital | 2007-04-01 |
| A Dose Escalation Study of SF1126, a PI3 Kinase (PI3K) Inhibitor, Given By Intravenous (IV) Infusion in Patients With Solid Tumors (NCT00907205) | Semafore Pharmaceuticals | 2007-04-01 |